1. All Stories
  2. Politics
  3. Economy
  4. World
  5. Nuclear
  6. Society/Culture
  7. Space/Science
  8. Sports
  9. Tourism
  10. Other Media
  11. Videos
  12. Photos
  13. Cartoons
  14. Interview
    • فارسی
    • عربی
    • Türkçe
    • עברית
    • Pусский
  • RSS
  • Telegram
  • Instagram
  • Twitter
  • Facebook
  • All Stories
  • Politics
  • Economy
  • World
  • Nuclear
  • Society/Culture
  • Space/Science
  • Sports
  • Tourism
  • Other Media
  • Videos
  • Photos
  • Cartoons
  • Interview

COVID Daily Death Toll in Iran Down to 42

  • March, 28, 2022 - 15:08
  • Society/Culture news
COVID Daily Death Toll in Iran Down to 42

TEHRAN (Tasnim) – The daily deaths from the coronavirus in Iran decreased again on Monday, standing at 42.

Society/Culture

According to the figures released by the Iranian Health Ministry on Monday, the total number of deaths from COVID-19 in the country has reached 140,063, as the disease has taken the lives of 42 patients over the past 24 hours.

Since yesterday, 2,915 new cases of COVID-19 infection were reported, with 350 of them hospitalized, the ministry added.

More than 6,858,700 individuals have recovered or been discharged from hospitals out of a total of 7,154,000 ones who have contracted the disease, it said.

Some 1,513 victims of COVID-19 are in severe condition and are being treated in intensive care facilities, it added.

The ministry also said that over 63.84 million Iranians have received the first dose of the coronavirus vaccine, over 56.77 million have received the second dosage, and more than 26.03 million have gotten the booster shots.

The number of people infected with COVID-19 across the world has surpassed 482 million and the death toll has exceeded 6.14 million.

 
R42340/P42410
Related topics
  • coronavirus
Read more
Over 1,300 New COVID Cases Detected in Iran
tasnim
tasnim
tasnim
  • About
  • Contact Us
  • Most Visited
  • Archive
Follow Us:
  • RSS
  • Telegram
  • Instagram
  • Twitter
  • Facebook

All Content by Tasnim News Agency is licensed under a Creative Commons Attribution 4.0 International License.